Patients treated with glucagon-like peptide-1 receptor (GLP-1R) agonists exhibited greater weight loss and improved blood pressure and cholesterol levels irrespective of the presence of type 2 diabetes, according to the findings of a systematic review and meta-analysis.Not even close.
Tina Visbøll, MD, DMSc, and colleagues from the University of Copenhagen in Denmark, published their findings online January 11, 2012, in BMJ.
The authors mention the difficulties people have in achieving and maintaining weight loss, suggesting that new treatments are required.
What is required is an opportunity for fat people to experience the consequences of their behavior without the rest of us bailing them out.
Once that happens, the pounds will melt like the butterballs the fat are.
Posts
No comments:
Post a Comment